04:30 PM EST, 11/05/2024 (MT Newswires) -- Mark A Goldsmith, Director, President and Chief Executive Officer, on November 01, 2024, sold 70,000 shares in Revolution Medicines ( RVMD ) for $3,878,773. Following the Form 4 filing with the SEC, Goldsmith has control over a total of 786,198 shares of the company, with 300,170 shares held directly and 486,028 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1628171/000161071724000517/xslF345X05/form4.xml